(Q33384996)

26 July 2017

1 reference

title

Review article: second-generation thrombopoietin agents for treatment of chronic idiopathic thrombocytopenic purpura in adults (English)

1 reference

26 July 2017

1 reference

Masha S H Lam

1

1 reference

26 July 2017

publication date

12 June 2009

1 reference

Journal of Oncology Pharmacy Practice

26 July 2017

published in

1 reference

26 July 2017

volume

16

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

89-103

1 reference

Immune thrombocytopenic purpura

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Management of immune thrombocytopenic purpura in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Prevalence of immune thrombocytopenia: analyses of administrative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Thrombocytopenia caused by the development of antibodies to thrombopoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Pharmacodynamics and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1078155209337668

21 January 2018

Identifiers

DOI

10.1177/1078155209337668

1 reference

26 July 2017

1 reference